Back to search
FDAFDA · Food and drugs·Recall number Z-1013-2015

Syngo RT Therapist: The intended use of the SIEMENS branded ARTISTE, ONCOR and PRIMUS family of linear accelerator systems is to deliver X-Ray photon and electron radiation for the therapeutic treatment of cancer

Published February 4, 2015 · Recall initiated: January 2, 2015

Summary

FDA records medical device Class II recall Z-1013-2015, published February 4, 2015 and initiated January 2, 2015. Recalling firm: Siemens Medical Solutions USA, Inc; Status: Terminated; Reported quantity: 3; Lot: model # 08162815, serial #s 10010, 10046, 10586. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Combination of CTVision with syngo RT Therapist / syngo RT Oncologist 4.3.SP1 automatic registration in Adaptive Targeting might result in wrong offset calculations. Applying this offset can lead to patient mistreatment. Cone Beam imaging is not affected by this problem.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Medical Solutions USA, Inc
Distributor
UT, WI, NY
Lot
model # 08162815, serial #s 10010, 10046, 10586
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Syngo RT Therapist: The intended use of the SIEMENS branded ARTISTE, ONCOR and PRIMUS family of linear accelerator systems is to deliver X-Ray photon and electron radiation for the therapeutic treatment of cancer recalled?

Yes. FDA published recall Z-1013-2015 on February 4, 2015. Reported hazard: Combination of CTVision with syngo RT Therapist / syngo RT Oncologist 4.3.SP1 automatic registration in Adaptive Targeting might result in wrong offset calculations. Applying this offset can lead to patient mistreatment. Cone Beam imaging is not affected by this problem.

What should I do if I have this product?

Voluntary: Firm initiated · Letter